Literature DB >> 18005231

GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.

Ana I Rojo1, María Rosa de Sagarra, Antonio Cuadrado.   

Abstract

Oxidant injury activates the neuroprotective pathway represented by phosphatidylinositol 3 kinase (PI3K) and Akt. However, the final outcome of oxidant exposure is often associated with neuronal death. This study was aimed to identify the molecular mechanism responsible for loss of tolerance to an oxidative environment. In N2A neuroblasts, serum and H2O2 exhibited different kinetics of regulation for the Ser/Thr kinases Akt and glycogen synthase kinase 3beta (GSK-3beta) and for the transcription factor Nrf2, which governs redox homeostasis. Thus, H2O2 rapidly activated Akt, inhibited GSK-3beta, and directed the transcription factor Nrf2 to the nucleus, but after 4 h Akt was inactive, GSK-3beta was active and Nrf2 was more cytosolic than nuclear. Inhibition of the PI3K/Akt pathway by LY294002, impeded the short-term effect of H2O2 on nuclear translocation of Nrf2. GSK-3beta activation (inhibiting PI3K/Akt) or direct GSK-3beta inhibition in cerebellar granule neurons resulted in respective nuclear exclusion and nuclear accumulation of Nrf2. Moreover, in these neurons, nuclear accumulation of Nrf2 correlated with increased heme oxygenase-1 expression. Over-expression of the kinase active GSK-3beta (Delta9) mutant, induced Nrf2 cytoplasmic localization and inhibited Nrf2 transcriptional activity towards an antioxidant-response-element luciferase reporter. Moreover, GSK-3beta (Delta9) sensitized N2A neuroblasts to H2O2-induced oxidative stress and cell death. This study identifies GSK-3beta, a kinase known to participate in neurodegeneration, as a fundamental element in the down-regulation of the antioxidant cell defense elicited by Nrf2 after oxidant injury and provides a mechanism to explain the loss of oxidant tolerance that happens under persistent oxidant exposure such as those found in several neuropathologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005231     DOI: 10.1111/j.1471-4159.2007.05124.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  88 in total

Review 1.  Can Some Anticancer Treatments Preserve the Ovarian Reserve?

Authors:  Nicolas Vallet; Nicolas Boissel; Elisabeth Elefant; Florian Chevillon; Hélène Pasquer; Charlotte Calvo; Nathalie Dhedin; Catherine Poirot
Journal:  Oncologist       Date:  2021-01-29

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 3.  Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.

Authors:  Zhangsuo Liu; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2015-08-10       Impact factor: 8.860

Review 4.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

5.  Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β.

Authors:  Fernando Correa; Carina Mallard; Michael Nilsson; Mats Sandberg
Journal:  Neurobiol Dis       Date:  2011-07-02       Impact factor: 5.996

6.  GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.

Authors:  Barbara D'Angelo; C Joakim Ek; Yanyan Sun; Changlian Zhu; Mats Sandberg; Carina Mallard
Journal:  Neuropharmacology       Date:  2015-09-15       Impact factor: 5.250

7.  Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Authors:  Yongfang Jiang; Hui Bao; Yan Ge; Wei Tang; Du Cheng; Kaizhong Luo; Guozhong Gong; Rujun Gong
Journal:  Gut       Date:  2014-05-08       Impact factor: 23.059

8.  Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes.

Authors:  Ling Wang; Haiyan Jiang; Zhaobao Yin; Michael Aschner; Jiyang Cai
Journal:  Toxicol Sci       Date:  2008-09-23       Impact factor: 4.849

9.  Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Authors:  Vivek P Patel; Donald B Defranco; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2012-08-08

Review 10.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.